antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation
Nucleic Acids Research · 05.07.2023 · 51 (W1) · W46-W50
DOI: 10.1093/nar/gkad344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 04.05.2023. Verfasst von Kai Blin und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs.Lyngby, Denmark. Hauptthemen laut MEDLINE: Software, Computers. Die Arbeit wurde bisher 2509-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Novo Nordisk Foundation, Danish National Research Foundation.
Abstract (Originalsprache)
Microorganisms produce small bioactive compounds as part of their secondary or specialised metabolism. Often, such metabolites have antimicrobial, anticancer, antifungal, antiviral or other bio-activities and thus play an important role for applications in medicine and agriculture. In the past decade, genome mining has become a widely-used method to explore, access, and analyse the available biodiversity of these compounds. Since 2011, the ‘antibiotics and secondary metabolite analysis shell—antiSMASH’ (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free to use web server and as a standalone tool under an OSI-approved open source licence. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in archaea, bacteria, and fungi. Here, we present the updated version 7 of antiSMASH. antiSMASH 7 increases the number of supported cluster types from 71 to 81, as well as containing improvements in the areas of chemical structure prediction, enzymatic assembly-line visualisation and gene cluster regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs.Lyngby, Denmark.
- Molecular Biotechnology, Institute of Biology, Leiden University, Leiden, The Netherlands.
- Bioinformatics Group, Wageningen University, Wageningen, The Netherlands.
- Institute of Molecular Bio Science, Goethe-University Frankfurt, Frankfurt am Main, Germany.
- LOEWE Center for Translational Biodiversity Genomics. Frankfurt am Main, Germany.
- Institute of Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
ORCID-Profile: Kai Blin, Hannah E Augustijn, Zachary L Reitz, Mohammad Alanjary, William W Metcalf, Gilles P van Wezel, Tilmann Weber
Förderung
- NIGMS NIH HHS
- Novo Nordisk Foundation
- Danish National Research Foundation
- ERC Starting Grant
- Novel Antibacterial Compounds and Therapies Antagonising Resistance program
- Dutch Research Council
Zitieren
APA
Blin, K., Shaw, S., Augustijn, H. E., Reitz, Z. L., Biermann, F., Alanjary, M., Fetter, A., Terlouw, B. R., Metcalf, W. W., Helfrich, E. J. N., van Wezel, G. P., Medema, M. H., & Weber, T. (2023). antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Research, 51(W1), W46-W50. https://doi.org/10.1093/nar/gkad344
Vancouver
Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F, Alanjary M, et al. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Research. 2023;51(W1):W46-W50. doi:10.1093/nar/gkad344
BibTeX
@article{Blin2023,
author = {Blin, Kai and Shaw, Simon and Augustijn, Hannah E and Reitz, Zachary L and Biermann, Friederike and Alanjary, Mohammad and Fetter, Artem and Terlouw, Barbara R and Metcalf, William W and Helfrich, Eric J N and van Wezel, Gilles P and Medema, Marnix H and Weber, Tilmann},
title = {antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {W1},
pages = {W46--W50},
doi = {10.1093/nar/gkad344}
}
EUVIMED